Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $.01 par value per share, of CASI Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: January 11, 2018
| ETP GLOBAL FUND L.P. | |||
| By: | EMERGING TECHNOLOGY PARTNERS, LLC General Partner | ||
| By: | /s/ Wei-Wu He, Ph.D. | ||
| Name: | Wei-Wu He, Ph.D. | ||
| Title: | Managing Member | ||
| EMERGING TECHNOLOGY PARTNERS, LLC | |||
| By: | /s/ Wei-Wu He, Ph.D. | ||
| Name: | Wei-Wu He, Ph.D. | ||
| Title: | Managing Member | ||
| /s/ Wei-Wu He, Ph.D. | |||
| Wei-Wu He, Ph.D. | |||
